KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biolife Solutions (BLFS) Return on Capital Employed (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Return on Capital Employed for 15 consecutive years, with 0.05% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Capital Employed changed N/A to 0.05% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.05%, a N/A change, with the full-year FY2024 number at 0.01%, up 3.0% from a year prior.
  • Return on Capital Employed was 0.05% for Q3 2025 at Biolife Solutions, up from 0.05% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.14% in Q2 2023 to a low of 0.26% in Q3 2022.
  • A 5-year average of 0.03% and a median of 0.03% in 2021 define the central range for Return on Capital Employed.
  • Peak YoY movement for Return on Capital Employed: decreased -22bps in 2022, then surged 39bps in 2023.
  • Biolife Solutions' Return on Capital Employed stood at 0.07% in 2021, then soared by 81bps to 0.01% in 2022, then soared by 115bps to 0.0% in 2023, then tumbled by -711bps to 0.01% in 2024, then tumbled by -284bps to 0.05% in 2025.
  • Per Business Quant, the three most recent readings for BLFS's Return on Capital Employed are 0.05% (Q3 2025), 0.05% (Q2 2025), and 0.01% (Q1 2025).